Literature DB >> 6794826

Captopril-associated lymphadenopathy.

H Aberg, C Mörlin, G Frithz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6794826      PMCID： PMC1507704          DOI： 10.1136/bmj.283.6302.1297-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

Review 1.  Captopril in the treatment of clinical hypertension and cardiac failure.

Authors:  A B Atkinson; J I Robertson
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

2.  Captopril-associated agranulocytosis.

Authors:  P van Brummelen; R Willemze; W D Tan; J Thompson
Journal:  Lancet       Date:  1980-01-19       Impact factor: 79.321

3.  Proteinuria during long-term captopril therapy.

Authors:  D B Case; S A Atlas; J A Mouradian; R A Fishman; R L Sherman; J H Laragh
Journal:  JAMA       Date:  1980-07-25       Impact factor: 56.272
  3 in total
  2 in total

1.  Mediastinal lymphadenopathy in congestive heart failure: a sequential CT evaluation with clinical and echocardiographic correlations.

Authors:  Valérie Chabbert; Guillaume Canevet; Cécile Baixas; Michel Galinier; Valérie Deken; Alain Duhamel; Philippe Otal; Francis Joffre; Jacques Remy; Martine Remy-Jardin
Journal:  Eur Radiol       Date:  2003-12-19       Impact factor: 5.315

Review 2.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.